Thioctic Acid

2022 ◽  
pp. 931-931
Author(s):  
Anton C. de Groot
Keyword(s):  
Nature ◽  
1955 ◽  
Vol 176 (4486) ◽  
pp. 788-789 ◽  
Author(s):  
J. BORNSTEIN ◽  
BERYL D. HARTMAN

1961 ◽  
Vol 18 (1-4) ◽  
pp. 233-234
Author(s):  
Elena Businco ◽  
Luisa Businco ◽  
Mario Scoponi
Keyword(s):  

2015 ◽  
Vol 43 (3) ◽  
pp. 350-355 ◽  
Author(s):  
Jimin Kahng ◽  
Tae kwan Kim ◽  
Eun Yong Chung ◽  
Yee Suk Kim ◽  
Jeong Yeon Moon
Keyword(s):  

2016 ◽  
Vol 30 (6) ◽  
pp. 1016-1020 ◽  
Author(s):  
Li Chen ◽  
Jiaolong Wang ◽  
Glen Mouser ◽  
Yan Chun Li ◽  
Geno Marcovici

1963 ◽  
Vol 83 (7) ◽  
pp. 704-707 ◽  
Author(s):  
Yoshio Deguchi ◽  
Kazuo Nakanishi

BioFactors ◽  
1999 ◽  
Vol 10 (2-3) ◽  
pp. 169-174 ◽  
Author(s):  
S. Jacob ◽  
K. Rett ◽  
E. J. Henriksen ◽  
H.-U. Häring

2011 ◽  
Vol 14 (4) ◽  
pp. 87-89
Author(s):  
Dmitriy Valentinovich Lipatov ◽  
Gagik Radikovich Galstyan ◽  
Olga Mikhailovna Smirnova

This article addresses modern approach to diabetic retinopathy management. Administration of an agent, not included in the list of evidence basedmethods, such as thioctic acid, is not considered to be an appropriate practice.


Sign in / Sign up

Export Citation Format

Share Document